ARTA
FATE icon

A.R.T. Advisors’s Fate Therapeutics FATE Stock Holding History

A.R.T. Advisors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-18,141
Closed -$355K – 365
2019
Q4 		$355K Sell
18,141
-1,300
-7% -$20.6K 0.02% 973
2019
Q3 		$302K Buy
+19,441
New +$373K 0.02% 1045
2016
Q1 		– Sell
-49,795
Closed -$167K – 1453
2015
Q4 		$167K Buy
+49,795
New +$209K 0.01% 1262

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

A.R.T. Advisors's FATE Position: Q1 2020 in Review

A.R.T. Advisors sold out of Fate Therapeutics (FATE) in Q1 2020, closing a stake of 18,141 shares — an estimated $355K sold.

A.R.T. Advisors first reported a position in FATE in Q4 2015 and held it in 3 quarters. The position peaked at $355K in Q4 2019. 156 funds tracked by Wall St. Rank hold FATE as of Q1 2020.

  • A.R.T. Advisors reported no remaining Fate Therapeutics position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 18,141 Fate Therapeutics shares in Q1 2020, an estimated $355K.
  • A.R.T. Advisors first reported a position in Fate Therapeutics in Q4 2015 and held it in 3 quarters.
  • A.R.T. Advisors's Fate Therapeutics position peaked at $355K in Q4 2019.
  • 156 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.